Severe Dermatomyositis Triggered by Interferon Beta-1a Therapy and Associated With Enhanced Type I Interferon Signaling (original) (raw)

Interferons and Cancer

Robert Friedman

Journal of the National Cancer Institute, 1978

View PDFchevron_right

Fate of interferon-treated cells

Robert Friedman

Infection and Immunity, 1976

View PDFchevron_right

Case Series: Ulcerative Colitis, Multiple Sclerosis, and Interferon-Beta 1a

Guilherme Macedo

Inflammatory Bowel Diseases, 2010

View PDFchevron_right

Assessment of type I interferon signatures in undifferentiated inflammatory diseases: A Japanese multicenter experience

Naotomo Kambe

Frontiers in Immunology, 2022

View PDFchevron_right

Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases

Theresa Wampler Muskardin

Journal of Clinical Investigation, 2019

View PDFchevron_right

Type I Interferons Promote Fatal Immunopathology by Regulating Inflammatory Monocytes and Neutrophils during Candida Infections

Karl Kuchler

PLOS Pathogens, 2012

View PDFchevron_right

Interferon Alpha Treatment of Patients with Impaired Interferon Gamma Signaling

Alexandra Freeman

Journal of Clinical Immunology, 2013

View PDFchevron_right

Long-term Outcome of Schilder Disease Treated With Interferon-β

為聖 林

Pediatrics, 2019

View PDFchevron_right

Autoimmunity induced by interferon-α therapy for chronic viral hepatitis

Tilman Sauerbruch

Biomedicine & Pharmacotherapy, 1999

View PDFchevron_right

Infection Risk in Patients with Dermatomyositis Associated with Anti-MDA5 Antibodies: A Historical Cohort Study

Frederic Coutant

Biomedicines, 2022

View PDFchevron_right

Interferon -1b-neutralizing antibodies 5 years after clinically isolated syndrome

Hans-peter Hartung

Neurology, 2011

View PDFchevron_right

Antiviral activity of interferons

Robert Friedman

Bacteriological reviews, 1977

View PDFchevron_right

Impact of the COVID-19 Pandemic on the Delivery of Dermatological Care

Alexa Kimball

Current Dermatology Reports, 2022

View PDFchevron_right

Abstracts from current global literature: Immune reconstitution inflammatory syndrome

DIMPAL PATEL

Indian Journal of Sexually Transmitted Diseases and AIDS, 2015

View PDFchevron_right

Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus

Lorenzo Camellini

Digestive Diseases and Sciences, 1996

View PDFchevron_right

The Use of an Interferon-Gamma Release Assay as a Biomarker of Response to Anti-TNF-Alpha Treatment

Fabio Cacciapaglia

Drug Development Research, 2014

View PDFchevron_right

IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta

Kevin Cooper

Journal of Immunology, 1990

View PDFchevron_right

Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases

Robert Pesich

PLOS One, 2012

View PDFchevron_right

Immunoglobulin from systemic lupus erythematosus serum induces interferon release by normal mononuclear cells

francisco ramirez

Arthritis & Rheumatism, 1986

View PDFchevron_right

The role of type I interferons in non-viral infections

Jochen Mattner

Immunological Reviews, 2004

View PDFchevron_right

A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti–Jo-1 or anti–Ro 52/anti–Ro 60 autoantibodies

Maija-leena Eloranta

Arthritis & Rheumatism, 2007

View PDFchevron_right

Dermatologic manifestations in end stage renal disease

Mohammad Ali Shafiee

Hemodialysis International, 2018

View PDFchevron_right

A 16 Year-old Male with Lower Extremity Dermopathy

Ali Omar Ali

Journal of Pediatric Endocrinology and Metabolism, 2009

View PDFchevron_right

Modulation of the human cytokine response by interferon lambda-1 (IFN-λ1/IL-29)

Bill Jordan

Genes and Immunity, 2006

View PDFchevron_right

Inflammatory dermatoses in human immunodeficiency virus

sarita sanke

Indian Journal of Sexually Transmitted Diseases and AIDS, 2017

View PDFchevron_right

IKKβ Leads to an Inflammatory Skin Disease Resembling Interface Dermatitis

ANA PAOLA LOPEZ BRAVO

Journal of Investigative Dermatology, 2010

View PDFchevron_right

Autoimmunity Diseases of the Skin

Paulo Criado

Autoimmune Diseases, 2013

View PDFchevron_right

Characterization of regulatory T cells in patients with dermatomyositis

Wolfgang Hartschuh

Journal of Autoimmunity, 2010

View PDFchevron_right

Skin manifestations in vasculitis and erythema nodosum

P. Puttini

Clinical and …, 2006

View PDFchevron_right

Immune Modulating Drugs Used in Skin Disease and Most Bothering Side Effects

MANAL MURAD

International Journal of Advanced Research, 2020

View PDFchevron_right

Impaired HVJ-stimulated Interferon producing capacity in MPO-ANCA-associated vasculitis with rapidly progressive glomerulonephritis lead to susceptibility to infection

Kazuko Uno

Cytokine, 2020

View PDFchevron_right

Current best evidence from dermatology literature

Devinder Thappa

Indian Journal of Dermatology, Venereology and Leprology, 2009

View PDFchevron_right

Vasculitis confined to peripheral nerves

John Pollard

Brain, 1996

View PDFchevron_right

Interferon-alpha therapy in idiopathic thrombocytopenic purpura

Ömer DOĞRU

Pediatrics International, 2001

View PDFchevron_right

Pathogenicity of severe fever with thrombocytopenia syndrome virus in mice regulated in type I interferon signaling

Joon-seok Chae

Laboratory Animal Research, 2020

View PDFchevron_right